Studies have also revealed that TOPK expression levels and kinase activity are positively correlated with the number of cells at the G2/M phase in gastric carcinoma and prostate cancer, whereas silencing TOPK or inhibiting it activation can arrest the cell cycle in the G0 phase [50,51]. Here, PBK is linked to prostate carcinoma.